Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Jun 22, 2016
Insider Transaction Report
Form 4
WELCH JAMES H
Chief Financial Officer
Transactions
- Purchase
Common Stock
2016-06-22$19.79/sh+500$9,897→ 2,500 total - Purchase
Common Stock
2016-06-20$19.80/sh+2,000$39,592→ 2,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.695 to $19.8752, inclusive. The reporting person undertakes to provide to Eiger BioPharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.